diabetes
-
STARTUPS
Noom competitor OurPath rebrands as Second Nature, raises $10M Series A
Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of diabetes. The company helped customers…
Read More » -
Trends
Lack of transparency in healthcare startups risks another Theranos implosion
Are more Theranos-style scandals looming for investors in healthcare startups? A team of researchers associated with the Meta Research Innovation…
Read More »